SABBY MANAGEMENT LLC 13D and 13G filings for BiondVax Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 6:16 pm Sale | 2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 29,051 4.900% | -191,612 (-86.83%) | Filing |
| 2024-01-02 4:54 pm Sale | 2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 220,663 11.000% | -7,666 (-3.36%) | Filing |
| 2023-01-04 09:21 am Purchase | 2022-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 228,329 11.000% | 228,329 (New Position) | Filing |